281 related articles for article (PubMed ID: 36226166)
1. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
2. Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy.
Wei W; Liu C; Wang C; Wang M; Jiang W; Zhou Y; Zhang S
Front Genet; 2022; 13():1016797. PubMed ID: 36339001
[TBL] [Abstract][Full Text] [Related]
3. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
4. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
5. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
6. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
[TBL] [Abstract][Full Text] [Related]
8. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M
Front Oncol; 2022; 12():1055605. PubMed ID: 36761423
[TBL] [Abstract][Full Text] [Related]
9. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
Xu F; Cai D; Liu S; He K; Chen J; Qu L; Chong T; Li X; Ren B
Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
[TBL] [Abstract][Full Text] [Related]
10. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
[TBL] [Abstract][Full Text] [Related]
11. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
12. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
13. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
14. N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer.
Cai M; Yang C; Wang Z
Am J Cancer Res; 2023; 13(5):1640-1655. PubMed ID: 37293166
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern and prognostic value of key regulators for N7-methylguanosine RNA modification in prostate cancer.
Zhai Q; Hou Y; Ye Y; Dai S; Guo G; Yang Q; Pang G; Wei Q
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):561-573. PubMed ID: 36810782
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma.
Zhang Y; Gan W; Ru N; Xue Z; Chen W; Chen Z; Wang H; Zheng X
J Bone Oncol; 2023 Jun; 40():100481. PubMed ID: 37139222
[TBL] [Abstract][Full Text] [Related]
17. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
Front Genet; 2022; 13():930446. PubMed ID: 36110218
[No Abstract] [Full Text] [Related]
18. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S
Front Genet; 2022; 13():906496. PubMed ID: 35938009
[TBL] [Abstract][Full Text] [Related]
19. Identification of m7G-related hub biomarkers and m7G regulator expression pattern in immune landscape during the progression of osteoarthritis.
Chen Z; Hua Y
Cytokine; 2023 Oct; 170():156313. PubMed ID: 37549488
[TBL] [Abstract][Full Text] [Related]
20. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y
Front Oncol; 2022; 12():934928. PubMed ID: 35992788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]